![IJMS | Free Full-Text | Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA IJMS | Free Full-Text | Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA](https://www.mdpi.com/ijms/ijms-23-04890/article_deploy/html/images/ijms-23-04890-g009.png)
IJMS | Free Full-Text | Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA
![Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future? | Future Medicinal Chemistry Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future? | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.13.172/asset/images/medium/figure3.gif)
Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future? | Future Medicinal Chemistry
![Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future? | Future Medicinal Chemistry Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future? | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.13.172/asset/images/medium/figure4.gif)